Acitve substances in 1 ml suspension: Neomycin sulfate 3500 IU, Polymyxin B sulfate 6000 IU и Dexamethasone 1 mg Trio Vision eye drops, suspension is indicated for the short-term treatment of inflammatory ocular conditions where corticosteroid therapy is indicated, at...
In July 2020 PharmaVision Europe launched as first-to-market generic the brand TravoVis Combo eye drops. The product is subject to medical prescription and is used for treatment of glaucoma. The fixed combination contains travoprost (40mcg/ml) and timolol...
On 04 May 2018 the Health Fund of the Republic of Albania announced the entry into force of the new 2018 Reimbursement List. PharmaVision Europe has 4 ophthalmic products included as so called “referent” products on the reimbursement list – meaning...
On 20 April 2018 during the regular professional meeting of the Association of Ophthalmologists in the Republic of Macedonia, Farmatrejd Macedonia and PharmaVision Europe had the chance to introduce the new ophthalmic line of products recently launched in Macedonia....
In April 2018 PharmaVision Europe launches on key markets in Europe and in Central Asia new patented formula for Urinary Health – UROPROST tabl. x 60. The product is intended for peroral immunotherapy of acute or chronic non-specific infections of the urinary...
PharmaVision Europe participated in the 2nd Congress of ophthalmologists in Banja Luka, Republic of Srpska during the period 1-3 June 2017. PharmaVision Europe with it representative office for Bosnia and Herzegovina – PharmaVision BH presented the company’s new...
